- Home
- ETON vs LWAY Comparison
ETON vs LWAY Comparison
Compare ETON & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- LWAY
- Stock Information
- Founded
- ETON 2017
- LWAY 1986
- Country
- ETON United States
- LWAY United States
- Employees
- ETON N/A
- LWAY N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- LWAY Packaged Foods
- Sector
- ETON Health Care
- LWAY Consumer Staples
- Exchange
- ETON Nasdaq
- LWAY Nasdaq
- Market Cap
- ETON 498.8M
- LWAY 513.4M
- IPO Year
- ETON 2018
- LWAY 1987
- Fundamental
- Price
- ETON $18.35
- LWAY $24.26
- Analyst Decision
- ETON Strong Buy
- LWAY Strong Buy
- Analyst Count
- ETON 3
- LWAY 1
- Target Price
- ETON $29.67
- LWAY $33.00
- AVG Volume (30 Days)
- ETON 249.9K
- LWAY 98.0K
- Earning Date
- ETON 11-06-2025
- LWAY 11-13-2025
- Dividend Yield
- ETON N/A
- LWAY N/A
- EPS Growth
- ETON N/A
- LWAY N/A
- EPS
- ETON N/A
- LWAY 0.70
- Revenue
- ETON $58,181,000.00
- LWAY $193,021,000.00
- Revenue This Year
- ETON $105.25
- LWAY $14.66
- Revenue Next Year
- ETON $40.84
- LWAY $13.81
- P/E Ratio
- ETON N/A
- LWAY $34.45
- Revenue Growth
- ETON 85.40
- LWAY 9.19
- 52 Week Low
- ETON $8.24
- LWAY $19.50
- 52 Week High
- ETON $23.00
- LWAY $34.20
- Technical
- Relative Strength Index (RSI)
- ETON 45.34
- LWAY 29.46
- Support Level
- ETON $18.00
- LWAY $23.46
- Resistance Level
- ETON $18.92
- LWAY $27.10
- Average True Range (ATR)
- ETON 0.83
- LWAY 0.99
- MACD
- ETON -0.12
- LWAY -0.20
- Stochastic Oscillator
- ETON 45.30
- LWAY 16.64
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.